Testing fatigue and muscle effects after starting targeted therapy
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how starting “targeted” treatment affects fatigue and skeletal muscle function in people with severe axial spondyloarthritis. It may help doctors understand what to expect early after treatment starts and how well it impacts day-to-day energy and muscle performance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have axial spondyloarthritis confirmed by the ASAS criteria
- You have not started targeted therapy yet (or started it within the last 15 days)
- Your doctor has decided you should start targeted therapy
- You’re at least 18 years old and can sign consent to join
- If you can get pregnant, your pregnancy test is negative and you use effective birth control
- You can understand French well enough to follow the study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a high-intensity interval training program done at home can help reduce fatigue and muscle pain for people with stable lupus. It aims to see if this type of exercise is safe and beneficial.
This study follows people who were recently diagnosed with spondyloarthritis (a type of arthritis) to see how their symptoms change over time. It helps doctors understand the early stages of the disease better.
This trial is for people with rheumatoid arthritis or spondyloarthritis who haven't responded well to standard treatments. It aims to study and improve care for those needing advanced biologic or synthetic therapies.
This study is for people recently diagnosed with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine). It tests whether a standardized global review and education program can help patients better understand and manage their condition.
This study tests whether a supervised exercise program can help people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) who are already on biologic medications. It aims to see if exercise reduces inflammation and improves symptoms.
This trial tests an investigational drug for people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine and pelvis). It also includes a group of healthy volunteers for comparison. The study aims to see if the drug is safe and effective.
Hear when a new Fatigue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.